SAVE MONEY ON TRAVEL DEALS

University of Oklahoma Health Sciences Center researchers said the compound, which still faces several rounds of clinical trials, successfully stopped normal cells from turning into cancer cells and inhibited the ability of tumors to grow and form blood vessels.

If successful tests continue, researchers eventually hope to create a daily pill that would be taken as a cancer preventive.

"This compound was effective against the 12 types of cancers that it was tested on", said Doris Benbrook, the study's principle investigator. "Even more promising for health care is that it prevents the transformation of normal cells into cancer cells and is therefore now being developed by the National Cancer Institute as a cancer prevention drug."

The synthetic compound directly targets abnormalities in cancer cell components without damaging normal cells, researchers said. The disruption causes cancer cells to die and keeps tumors from forming.

Benbrook and her team have patented the discovery and hope to start clinical trials for the compound within 5 years.

 BREAKING STORIES

Bacterial link to colon cancer studied

Oklahoma Quarterback Sam Bradford Too Crafty for TCU's Defense

Inhofe: Obama's love of country in doubt

E. coli outbreak hospitalizes 40 in Okla.

Medication slows myopia progression

Fiery Oklahoma train derailment probed

Whistle-blower leaves hospital job

Mold found in wounded vets' barracks

Okla. AG urges poultry farmers to settle

Candidate's anti-gay comic book targets AG

Expert Says We Need Better Diet

'Idol' Cook to endorse Skechers shoes

The Norman Transcript, Okla., Clay Horning Column: It's Nice to See the Metro Join the Ranks of Major League Cities

Governor calls on state auditor to resign

Sonics Would Be Profitable Here, Bennett Testifies

Cholesterol drug may help hepatitis C

Compound might stop cancer progression

Oklahomans elect teen mayor

Oklahoma town unlikely to recover from tornado

Critics name `August: Osage County' best play